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ABSTRACT 
 
 Secondary metabolites produced by microorganisms were isolated and identified.  These 
metabolites are not essential for the growth of the producing culture, are usually synthesized as 
closely related members of a chemical family and include compounds that act as hormones, 
antibiotics and toxins.  In the first chapter, actinomycetes were isolated from local marine 
sediments and cultivated in order to determine bioact ve metabolites of interest.  Broad spectrum 
antibiotic compounds produced as constitutional isomers were isolated from a strain identified as 
Streptomyces malaysiensis.  Additionally, a family of compounds which selectively inhibited 
Mycobacterium smegamatis, a surrogate test organism used in the discovery of tuberculosis 
treatments, were isolated from a strain identified as Streptomyces fimicarius.  In the second 
chapter, microcystin-LR, a potent liver toxin, and its derivatives were isolated from laboratory 
cultures of Microcystis aeruginosa.  During the isolation of these toxic metabolites, additional 
unrelated peptides belonging to the microginin class of cyanopeptide metabolites were isolated 
and identified.  Structural determination of these fiv cyanopeptides revealed unique structural 
features including the amino acid methionine, various sites of methylation on the modified 
octanoic acid chain and the first tripeptide microginin.             
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INTRODUCTION 
Microorganisms are a rich source of structurally uniq e bioactive substances. Since the 
1940s, over 30,000 natural products have been discovered from microorganisms, more than 
10,000 of which are biologically active (Fenical 1993).  Several characteristics of 
microorganisms make them important sources of bioactive natural products.  Microorganisms 
have a high ratio of surface area to volume, facilit t ng the rapid uptake of nutrients required to 
support high rates of metabolism and biosynthesis.  Microbes are capable of carrying out a 
tremendous variety of reactions and can adapt to a range of environments allowing them to be 
transplanted from nature to the laboratory flask, where they can be grown on inexpensive carbon 
and nitrogen sources to produce valuable compounds (Demain 2000b).  Because of their 
biological activity, secondary metabolites of microbial origin are extremely important to our 
health and nutrition and have a tremendous economic importance.  The antibiotic market 
amounts to almost 30 billion dollars a year, with oer important pharmaceutical compounds 
from microbes having world markets of over 1 billion dollars per year.  Microorganisms, 
particularly culturable bacteria and cyanobacteria, are recognized as important renewable sources 
of pharmaceuticals (Ireland et al 1993).  Most notably, bacteria within the order Actinomycetales 
have been shown to possess an unparalleled ability to produce diverse secondary metabolites 
with a range of biological activities (Davidson 1995).   These morphologically diverse gram 
positive soil bacteria, known collectively as actinomycetes, are a prolific source of antibiotics 
and have been the focus of numerous research efforts since the discovery of actinomycin from 
Actinomyces antibioticus by Selman Waksman at Rutgers University in 1940 (Waksman 1940).  
In fact, actinomycete compounds or derivatives thereof accounted for approximately two thirds 
of the naturally occurring antibiotics discovered as of 1988, making them the single most 
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important source of prescription drugs (Jensen et al. 2003).  However, new bioactive metabolites 
from terrestrial actinomycetes are becoming increasingly difficult to discover, due to repeated 
isolation of common species and subsequent rediscovery of large numbers of previously 
described metabolites.  This along with the increased incidence of naturally resistant pathogens 
makes it imperative that new sources of bioactive natural products be developed (Demain 2000a, 
Fenical 1993).   
Oceans cover approximately 70% of the planet and cotain organisms with broad 
biodiversity and complex ecology, underscoring the proposal that the marine environment offers 
a remarkable opportunity as a source of novel compounds.  The bactericidal properties of 
seawater began to be recognized as early as the 1930s (ZoBell 1936), attributed to antibiotic 
producing bacteria and planktonic algae.  The firstdocumented bioactive marine microbial 
metabolite was isolated by Burkholder and co-workers in 1966 from a marine Pseudomonas sp. 
(Burkholder 1966).  The structure of this unique highly brominated pyrrole antibiotic is shown in 
Figure 1.  Since then, extensive chemical studies on marine organisms have yielded over 6,000 
unique metabolites featuring new structural classes, functional groups and a relatively high 
incidence of halogenation (Jensen and Fenical 1994).  Early studies, targeting marine 
invertebrates such as sponges, soft corals, and bryozoans, have demonstrated that marine 
organisms indeed possess the ability to produce unique secondary metabolites.  These sources, 
however, are limited by supply.  When possible, massive collection efforts of these marine 
invertebrates are not only expensive and time consuming, but are also potentially damaging to 
tropical habitats (Davidson 1995).   
Marine flora and fauna have developed symbiotic relationships with numerous microorganisms, 
particularly bacteria.  Indeed, the importance of bacterial symbiosis has given increasing 
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recognition to bacteria as the true producers of many compounds isolated from sponges and other 
marine invertebrates (Fenical 1993).  Despite this,relatively little attention was directed towards 
the study of marine bacterial metabolites, due to a widespread perception that marine bacteria 
were extremely difficult to isolate and cultivate, with culturability rates as low as 0.1 to 0.01% 
typically reported.  These rates, however, reflect attempted cultivation in standard nutrient 
conditions and do not consider the adaptations these marine bacteria have acquired, such as the 
requirement of salt water for growth.  Simple media modifications, such as nutrient limitation 
and pretreatments, have been found to increase culturabilty rates of marine actinomycetes in 
excess of 50% (Jensen et al. 2003; Piret and Demain 1988).   
Early studies of marine bacteria showed that seawater was composed mostly of gram-
negative bacteria, with gram positive bacteria representing less than 10% of the total seawater 
population.  Despite the abundance of gram negative m crobes in seawater, the majority of 
marine antibiotic producers were found to be gram positive bacteria.  Evidence now suggests that 
gram positive bacteria exist in high percentages in marine sediments, animate and inanimate 
surfaces, and internal spaces of invertebrate animals.  The best marine sources of actinomycetes 
studied thus far are sediments (Fenical 1993; Zheng et al 2000). Representative structures of 
several bioactive actinomycete metabolites isolated from marine sediments are shown in Figure 
2.  Istamycins, aplasmomycins, and altemicidin, isolated by researchers at the Institute of 
Microbial Chemsitry in Tokyo, were produced by various actionomycetes isolated from marine 
sediment samples collected from Sagami Bay, Japan.  These metabolites were found to be 
produced only in selected seawater media containing the Japanese seaweed product “Kobu Cha.”  
Kobu Cha is a dried powder derived from the brown seaweed Laminaria.  Interestingly, 
istamycins are aminoglycoside antibiotics that resembl  fortimicins and sporaricins, a closely  
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Figure 1. The first reported bioactive metabolite from a marine microorganism 
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related group of aminoglycosides isolated from terrest ial actinomycetes.  Istamycins, however, 
may be more therapeutically important because of their activity against aminoglycoside-resistant 
pathogens (Fenical 1993; Okami et al 1979).  Asplasmomycins are large boron-containing 
compounds with antibiotic activity (Nakamura et al 1977), and altemicidin is a structurally novel 
alkaloid with potent anticancer activity (Takahashi et al 1989).  Marinone is a brominated 
sesquiterpenoid napthoquinone antibiotic isolated from marine sediments collected at Torrey 
Pines Estuary in La Jolla, California (Pathirana et l 1992).    
On one hand, marine sediments have proved to be a prolific resource for the isolation of 
marine bacteria with the ability to produce structurally unique bioactive secondary metabolites 
and as new and unusual strains are isolated, it is likely that new metabolites will be discovered. 
On the other hand, it has been proposed that actinomycetes isolated from marine habitats are not 
indigenous marine bacteria, but instead originate from spores of terrestrial actinomycetes that 
have been washed to sea.  However, recent studies hav  s own that the distribution of 
actinomycetes in marine sediments and the requirements of seawater for growth give conclusive 
evidence that actinomycetes adapted to the marine environment represent a physiologically 
unique class of microorganisms (Jensen et al 1991).  In fact, researchers at Scripps Institution of 
Oceanography have identified two new taxa of marine bacteria within the order Actinomycetales 
discovered from ocean sediments:  The genus Salinospora and the new marine actinomycete 
with the proposed genus “Marinispora” (Mincer et al 2002; Feling et al 2003; Kwon et al 2006).  
These strains have been consistently and exclusively isolated from marine sediments, are 
distinguished by morphological characteristics, share a unique small subunit rRNA signature 
nucleotide, and display saltwater requirements for gr wth.  Salinospora strain CNB-392 was 
found to produce the unique metabolite, Salinosporamide A, which exhibits potent cancer cell 
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Figure 2. Selected bioactive compounds from marine actinomycetes: their source, origin and 
biological activity.   
 Metabolite Producing strain Source Activity Class Reference 
a 
 
 
b 
 
 
c 
 
 
d 
 
Istamycin 
 
 
Altemicidin 
 
 
Marinone 
 
 
Asplasmomycin 
Streptomyces 
tenjimariensis 
 
Streptomyces  
sioyaensis 
 
Streptomyces sp. 
 
 
Streptomyces  
griseus 
Marine sediment 
 
 
Marine sediment 
 
 
Marine sediment 
 
 
Marine sediment 
Antibiotic 
 
 
Anticancer 
 
 
Antibiotic 
 
 
Antibiotic 
Aminoglycoside 
 
 
Alkaloid 
 
 
Napthoquinone 
 
Okami et al 1979 
 
 
Takahashi et al 1989 
 
 
Pathirana et al 1992 
 
 
Nakamura et al 1977 
 8 
toxicity towards HCT-116 human colon carcinoma (Feling et al 2003).  A recent publication 
describes the isolation of four macrodiolide antibiotics, marinomycins A-D from Marinispora 
strain CNQ-140 that exhibit impressive cancer cell toxicities against eight melanoma lines in the 
NCI’s 60 cell line panel (Kwon et al 2006).  The structures of Salinosporamide A as well as 
Marinomycins A-D can be seen in Figure 3.  Additionally, chemical analyses of other 
Salinospora and Marinispora isolates have shown the production of a significant number of 
diverse secondary metabolites that are currently under investigation.  Clearly, the evidence points 
to marine derived actinomycetes as a major source of bioactive metabolites with unique 
structural features and activities that represent an exciting biomedical resource (Fenical and 
Jensen 1993). 
Infectious diseases are rapidly developing resistance towards traditional antibiotics, 
perpetuating the need for safer, more potent, and broader spectrum compounds (Demain 2000a).  
For example, recently observed strains of Mycobacterium tuberculosis have developed multiple 
drug resistance and antibiotics to control this specific bacterium are simply not available (Fenical 
1993).  Mycobacterium tuberculosis requires Biosafety Level 3 containment, making it difficult 
to perform activity testing in an ordinary lab setting.  Recent studies have demonstrated the 
utility of using Mycobacterium smegmatis, a non-pathogenic cousin of M. tuberculosis, as a 
surrogate test organism.  M. smegmatis grows much faster than M. tuberculosis and allows 
testing in an ordinary lab without extra safety precautions (Reyrat and Kahn 2001).   
The focus of the work described in this portion of the thesis was to explore the potential 
of actinomycetes isolated from the coastal waters of North Carolina as sources of new 
biologically active compounds of therapeutic interest to the pharmaceutical industry.   
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Figure 3. The structures of bioactive metabolites from new marine actinomycete genera 
(a) Salinosporamide A from Salinospora ; (b) Marinomycin A from Marinispora  
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EXPERIMENTAL 
Collection and Isolation of Actinomycetes from Marine Sediments 
 Near shore mud samples were collected using a sterile plastic syringe and transferred to a 
sterile Falcon tube (50 ml).  Sediment samples were vigorously shaken by hand to ensure 
uniformity and then allowed to settle.   The overlaying water was decanted off and used for pH 
and salinity measurements.  Sediment samples were dilut d with sterilized filtered seawater 
(1:10) and incubated (550C, 1 hr).  The dilution was then vortexed (1 min) ad mixed using a 
nutator (30 min).  Each sample (100 µl) was plated on duplicate agar plates (See Table 1 for 
media recipes).   Plates were then incubated (250C) for 7-45 days.  Potential actinomycete 
colonies, identified by morphological characteristic  and gram staining in collaboration with 
microbiologists at aaiPharma, were continually transferred to fresh agar plates until pure colonies 
were obtained.  Pure colonies of potential actinomycetes were sent to Accugenix (Newark, DE) 
for phylogenetic analysis using 16S ribosomal DNA sequence comparison.  After identification, 
liquid cultures of positively identified colonies were frozen for storage in DMSO (20% v/v, 0.6 
ml) in sterile tubes (1.0 ml) and kept at -700C until use.   
Culture Methods 
 Isolates were cultured in various production mediums (See Table 1 for media recipes).  
Cultures were transferred from slants to production media (5 ml).   After 3 days of growth in 
small tubes, cultures were aseptically transferred to larger tubes (20 ml) and after 5 days, 
transferred again to flasks (300 ml).  Cultures were grown on an orbital shaker in 1 l Erlynmeyer 
flasks for 7-10 days (200 rpm, 250C).  Initially, individual isolates were grown six at a time, with 
two flasks per organism (600 ml total culture) in order to obtain an initial activity profile.  
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Isolates displaying strong or interesting bioassay activity in the crude extracts were then cultured 
in larger scale, twelve flasks at a time (3.6 L total culture).   
Extraction Methods 
 Media and cells were filtered using Whatman GF/A filter papers.  Cells on the filter paper 
were extracted once (500 ml 80% MeOH, 24 hrs.).  Filtered culture media was partitioned 
against ethyl acetate (3:1, 3 x) and butanol (3:1, 2 x).   The two fractions resulting from the 
partitioning as well as the cell extract were dried on a rotary evaporator and subjected to 
antimicrobial testing and TLC analysis.   
Chromatography Methods 
 Thin layer chromatography was performed on normal ph se glass backed 
chromatography plates with fluorescent UV indicator (Silica Gel 60 F254).  Extracts and fractions 
were chromatographed using mobile phase composed of butanol-acetic acid-water (12 : 3 : 5).  
Plates were visualized with short wavelength UV andsprayed with vanillin (0.5 g) in sulfuric 
acid-ethanol (4:1, 100 ml).  After spraying, plates were heated and observed for color changes.   
 Initial fractionation was performed using Supelco ENVI-18 SepPak cartridges followed 
by partitioning on Sephadex LH-20 (25-100 µm).  Final purification was achieved by high 
performance liquid chromatography (HPLC; Waters SunFire C18).  LCMS was performed using 
a Waters Symmetry Shield RPC18 column.  Solvents used were HPLC grade methanol, 
acetonitrile, ethyl acetate, 1-butanol, acetic acid n  formic acid (FA) purchased from Fisher 
scientific.  Water was purified by Labconco Water Pro lus water deionization system.  
Preparative HPLC was performed using Waters pumps (515), gradient controller, and dual 
wavelength detector (2487).   
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Isolation Media  
AIA 1.0 L Deionized water (DIW) 
22 g Actinomycete Isolatoin Agar (Difco) 
5.0 g glycerol 
M4 1.0 L Sterile Filtered Seawater (75 ppt) 
2.0 g chitin 
18 g Agar 
M4100 1.0 L Sterile Filtered Seawater (75 ppt) 
2.0 g chitin 
18 g Agar 
100 µg/ml cycloheximide 
 
 
 
Production Media  
P3 1.0 L Sterile Filtered Seawater (75 ppt) 
10 g starch 
1.0 g yeast extract 
1.0 g peptone 
Marine Broth 1.0 L Deionized water (DIW) 
18 g Marine Broth (Difco) 
7.5 g tryptone 
9 g NaCl 
LM 1.0 L Sterile Filtered Seawater (75 ppt) 
0.1 g Laminaria (Sigma) 
0.1 g glycerol 
 
 
 
 
 
 
 
Table 1. Isolation and production media recipes 
 13 
Analytical Methods 
ESI-MS data was obtained using a Hewlett Packard Seies 1100 HPLC connected to a 
Waters Micromass ZQ with electrospray ionization (capillary voltage 3.0 kV; cone voltages 
10V/30 V; source temperature 140; desolvation temperature 350; cone gas flow 100; desolvation 
gas flow 600).  All samples were run in positive ion mode with a mass range of 100-1400 and a 
scan time of 0.5 sec.  Accurate molecular weight data was obtained using a quadrupole time of 
flight mass spectrometer (Applied Bioscience-MDS Sciex QStar XL).   
 Nuclear magnetic resonance (NMR) experiments were p formed on a Bruker Avance 
500 MHz NMR at 293.9 K.  Probes used include a 5.0 mm BBO, 5.0 mm TXI, and 1 mm TXI.  
NMR solvents (d4-methanol; d5-pyridine) were purchased from Cambridge Isotopic 
Laboratories.     
Bioassay  
 Crude extracts were tested for antimicrobial activity using a disc diffusion assay.   Test 
organisms used were the gram positive bacteria Bacillus subtilis and Mycobacterium smegmatis, 
the gram negative bacteria Escherichia coli, the yeast Candida kefyr and the filamentous fungus 
Aspergillus niger.  Sterile tubes containing media (5ml) were inoculated in duplicate with the 
bioassay organisms and incubated (24 h).  E .coli, B. subtilis, and M. smegmatis were grown in 
nutrient broth and incubated at 370 C, while C. kefyr and A. niger were grown in potato dextrose 
broth and incubated at 240C.  Aliquots of extracts to be tested (20 µl) were loaded in duplicate on 
to ¼ inch sterile filter paper discs and placed on agar plates containing 100 µl of the test 
organisms.  Plates were inverted and grown under appropriate conditions for 3 days, checking for 
activity daily.   
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Bioassay guided fractionation  
Isolate 4: Streptomyces malaysiensis (Figure 4) 
Streptomyces malaysiensis was cultivated in a production media containing 1% starch, 0.1% 
yeast, and 0.1% peptone in 75 ppt sterile filtered s awater (SFSW).  Both the ethyl acetate and 
butanol crude extracts from this isolate showed activity against all organisms tested.  Both 
extracts were fractionated in the same manner.  Fractionation of each active crude extracts began 
with a Sep-Pak C18 cartridge (10 g/60 ml). The crude extracts were resuspended in 20% aqueous 
methanol (2.0 ml), applied to the column and eluted with an increasing methanol gradient (20 to 
100%) to yield a total of 5 fractions.  Each fraction was collected separately and tested for 
antimicrobial activity.  Activity was conserved in the 100% methanol fraction in both the ethyl 
acetate and butanol crude fractionation.  These fractions were combined, dissolved in 100% 
methanol (2.0 ml), loaded onto an LH-20 column (19 x 1.0 cm) and eluted with two column 
volumes of 100% methanol (50 ml).  Fractions (1 ml) were collected using a RediFrac fraction 
collector.  TLC was used to determine the chemical profile of these fractions. Plates were 
developed and analyzed, and fractions containing comm n spots were combined and further 
tested for antimicrobial activity.  All fractions displaying biological activity against all the test 
organisms consistently displayed a purple stain with vanillin, and where appropriate this was 
used to guide the fractionation process.  HPLC-DAD-ESIMS analysis on these combined 
fractions using a Waters Symmetry Shield RPC18 column (2.1 x 150 mm, 20-80% acetonitrile/ 
0.05% TFA over 30 min, 0.2 ml/min) revealed two major peaks.  These two peaks were purified 
by HPLC-UV using a Waters SunFire C18 column (10 x 250 mm, 30-65% acetonitrile / 0.1% FA; 
flow rate 2.5 ml/min; detection 232 and 214 nm), yielding 9 (rt = 14.4 min) and 10 (rt = 18.3 
min).  Both peaks were tested for antimicrobial activity and analyzed by NMR in d5-pyridine  
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Streptomyces malaysiensis Filtered Culture Broth
SepPak C18 column
20% MeOH        40% MeOH           60% MeOH        80% MeOH         100% MeOH
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Figure 4. Fractionation scheme for Isolate 4 (Streptomyces malaysiensis) 
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(see Appendix A).  Additional biological and analytical data for each compound are reported 
below. 
I4a (9): UV λmax (MeOH) 232 nm; ESIMS m/z 1143 [M+H]+;  high resolution MS m/z 
1142.6935 
I4b (10): UV λmax (MeOH) 232 nm; ESIMS m/z 1143 [M+H]+; high resolution MS m/z 
1142.6935 
Isolate 29: Streptomyces fimicarius (Figure 5) 
Streptomyces fimicarius was cultivated in a production media containing marine broth 
(Difco), tryptone, and NaCl in deionized water (see Table 1).  The crude butanol extract of this 
isolate showed selective activity against M. smegmatis.  Fractionation of this active crude 
extracts began with a Sep-Pak C18 cartridge (10 g/60 ml). The crude extract was resuspended in 
25% aqueous methanol (2.0 ml), applied to the column and eluted with a methanol gradient (25 
to 100%) providing a total of 4 fractions.  Each fraction was collected separately and tested for 
antimicrobial activity.  Activity was conserved in the 50% and 75% methanol fractions.  These 
active fractions were combined, dissolved in 100% methanol (2.0 ml) and loaded onto an LH-20 
column (19 x 1.0 cm).  The mixture was eluted with two column volumes of 100% methanol (50 
ml) and fractions (1 ml) were collected using a RediFrac fraction collector.  TLC was used to 
determine the chemical profile of these fractions. Plates were developed and analyzed, and 
fractions containing common spots were combined and further tested for antimicrobial activity.  
Activity against M.smegmatis was seen only in those combined fractions that stained yellow and 
contained a UV-quenching spot.  LC/MS was performed on the combined active fractions using 
a Waters Symmetry Shield RPC18 column (2.1 x 150 mm, 20-80% acetonitrile/ 0.05% TFA over 
30 min; 0.2 ml/min).  1D and 2D homonuclear and heteronuclear NMR experiments were 
 17 
performed in order to characterize the chemical nature of this active fraction (see Appendices B 
and C).  Additional biological and analytical data for each compound are reported below.  
 I29a (11): UV λmax (MeOH) 270 nm; high resolution MS m/z 1015.6242 
I29b (12): UV λmax (MeOH) 270 nm; high resolution MS m/z 1031.6151 
 I29c (13): UV λmax (MeOH) 270 nm; high resolution MS m/z 981.6327 
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Figure 5. Fractionation scheme for Isolate 29 (Streptomyces fimicarius) 
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Cytotoxicity Assay 
 Active compounds from isolate 4 (Streptomyces malaysiensis) were also tested for 
cytotoxicity against murine fibroblast cells (NCTC clone L-929) using an MTT based 
spectrophotometric assay.  This assay was performed by Candace Jones at aaiPharma.   
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RESULTS 
Isolation of Actinomycetes from Near Shore Sediments 
Sediment samples were taken from the dock at CMS (April 15, 2004 and May 12, 2004), 
along the Cape Fear River (June 8, 2004), as well as various sites in the Florida Keys (July 15, 
2005).  A total of 50 clones were isolated and positively identified as actinomycetes, 
encompassing 20 different species with varying differences in genetic divergence.  The 
distribution, media used in isolation, genetic identification and activity of these marine sediment 
derived actinomycetes can be seen in Table 2.  Micromonospora species were dominant in the 
sediments collected from the Dock at CMS, while Streptomyces species were dominant in 
sediments collected along the Cape Fear River.  Sediment samples collected in the Florida Keys 
resulted in only two actinomycete species, however salinity measurements revealed that these 
samples originated from a much more saline environment than other sampling locations. 
Initial Activity Testing 
 26 of the 50 isolates, representing one of each identified species as well as some 
replicates with larger differences in genetic divergence, were grown in 600 ml scale.  The cell 
extract as well as ethyl acetate and butanol extracts of the culture broth of each were tested for 
activity in a series of antimicrobial disc diffusion assays.  10 of these 26 isolates (38.5%) showed 
activity against one or more test organism.  Two of these isolates, Streptomyces malaysiensis 
(isolate 4) and Streptomyces fimicarius (isolate 29) were chosen for large scale cultivation.  
Isolate 4 showed broad spectrum antimicrobial activity whereas isolate 29 selectively inhibited 
Mycobacterium smegmatis.   
Bioactive Metabolites from Streptomyces malaysiensis 
 This isolate (isolate 4) was obtained from sediment samples collected in June of 2004 
 21 
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Table 2. Distribution, isolation media, genetic identification and activity of marine sediment 
derived actinomycetes 
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along the Cape Fear River.  Original sediment samples were plated onto agar plates of 
Actinomycetes Isolation Agar (AIA, see Table 1 for recipe) and continual transfer yielded a pure 
leathery colony with a powdery white surface identified as Streptomyces malaysiensis (1.19% 
difference).  After cultivation and harvest, crude extracts were tested using a disc diffusion assay.  
Crude ethyl acetate and butanol extracts of filtered culture media were found to inhibit all 
organisms tested.  Bioassay guided fractionation using reversed phase and gel permeation 
chromatography was used to isolate the compound(s) responsible for activity (Figure 4).  Further 
clean up by preparative HPLC resulted in two major peaks, both of which displayed broad 
spectrum activity as observed in the original crude extracts.  HPLC-DAD-ESIMS analysis 
revealed that both peaks had the same UV absorbance (λmax =232 nm; Figure 6) and molecular 
weight (m/z 1143, [M+H]+).  The HPLC chromatogram as well as the electrospray ositive mass 
spectra are shown in Figure 7.  Final purification of the products has not yet been achieved, but 
initial NMR analysis suggests that these compounds contain a polyhydoxy- or polyether-polyene 
structure, as evidenced by numerous protons under oxygen (δ 3.0 -δ 4.0) and several olefinic 
resonances (δ 5.2, δ 5.4, δ 5.6, and δ 6.0).  Furthermore, the UV chromophore (λmax 232 nm) is 
consistent with a conjugated diene system.  The absnce of low field resonances below δ 6.5 
makes the presence of any aromatics unlikely.  Additionally, the ESI-MS isotopic pattern of the 
parent ion does not suggest the presence of any halogenation.  Cytotoxicity activity of this 
extract was determined using an MTT based spectrophot metric assay and revealed activity 
comparable with Triton-X.   
Streptomyces malaysiensis was additionally cultured in a production media containing the brown 
seaweed Laminaria (LM, see Table 1).  The crude extracts of the filtred culture media retained 
inhibition against all organisms tested.  Additionally, LCMS analysis revealed that the active  
 23 
 
 
 
AKD 2-78-1
nm
210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400
A
U
0.0
5.0e-2
1.0e-1
1.5e-1
2.0e-1
2.5e-1
3.0e-1
3.5e-1
4.0e-1
4.5e-1
5.0e-1
5.5e-1
AKD 2-78-1 1956 (12.995) Cm (1944:1968) 3: Diode Array 
6.362e-1232.0
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. UV data for Streptomyces malaysiensis active compounds 
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Figure 7. Diode Array (above) and ESIMS (below) data for Streptomyces malaysiensis active 
compounds 
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metabolites (m/z 1143) were still produced.  
Bioactive metabolites from Streptomyces fimicarius (Isolate 29) 
 Isolate 29 was also obtained from sediment samples collected in June of 2004 along the 
Cape Fear River.  Original sediment samples were plat d onto agar plates of a chitin containing 
media supplemented with 100 µg/ml cyclohexamide (M4100, see Table 1 for recipe).  Continual 
transfer yielded a pure leathery concentric colony, greenish gray in color that was identified by 
genetic analysis as Streptomyces fimicarius (0.80% difference).  After cultivation and harvest, 
crude extracts were tested using a disc diffusion assay.  The crude butanol extract was found to 
selectively inhibit Mycobacterium smegmatis.  Once again, bioassay guided fractionation was 
used to determine the compound(s) responsible for activity (Figure 5).  In this case, gel 
permeation clean-up resulted in the isolation of three related compounds that collectively 
inhibited Μycobacterium smegmatis.  HPLC-DAD-ESIMS analysis revealed that these three 
metabolites all share a common UV absorbance (λmax =270 nm; Figure 8) and contain common 
fragment ions ([M+H]+, m/z 337, 319, 295, 241, 227, 159, 126)( Figure 9).  The parent ions have 
been difficult to identify.  When these three compounds were analyzed by ESIMS at various 
cone voltages and mobile phase modifiers, fragment ions at m/z 462, m/z 488, and m/z 502 were 
always dominant.  In contrast, Q-tof HRMS analysis ielded parent ions at m/z 981, m/z 1015, 
and m/z 1031, confirmed by isotopic pattern and the presence of sodium adducts.  It is possible 
that ESIMS results in doubly charged ions, or that e molecule is a symmetrical dimer that is 
cleaved under ESIMS conditions.  Regardless, at the moment it is not certain how these 
compounds fragment to the resulting masses.  Preliminary NMR studies (in d4-methanol) were 
performed on this mixture as a preliminary step to characterize the nature of these active  
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Figure 8. UV data for Streptomyces fimicarius active compounds 
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Figure 9. Diode Array (above) and ESIMS (below) data for Streptomyces fimicarius active 
compounds 
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metabolites.  1H resonances from δ .7- δ 1.35 showed correlations with 13C resonances in the 
region δ 12-30 and could be attributed to a long acyl chain.  Additionally, HSQC correlations 
between 1H shifts of δ 3.6, δ 4.0 and δ 4.2 with 13C shifts of δ 68, δ 71 and δ 72 respectively, 
were consistent with protonated carbons linked to oxygen. The lack of olefinic resonances as 
well as the weak UV absorbance indicates no conjugation in this acyl chain.  Additional 1H 
aromatic resonances at δ 7.05 and δ 6.75 as well as δ 7.25 were consistent with the presence of 
aromatic rings and the HSQC correlations (δ 7.05, δ 132; δ 6.75, δ 116) suggested the presence 
of the aromatic amino acid  tyrosine as well as phenylalanine (δ 7.25, δ 129).  Furthermore, 1H 
resonances at δ 4.22 and δ 4.1 which were correlated with carbons resonating at δ 59 and δ 61, 
were consistent with α-hydrogens of an amino acid, supporting the presence of amino acids in 
the structure.   
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DISCUSSION 
This project began in the spring of 2004.  Since then more than fifty actinomycete strains 
have been isolated from local and tropical marine sediments many of which display interesting 
and potent biological activity.  Two of the most promising strains (Streptomyces malaysiensis 
and Streptomyces fimicarius) have been mass cultured and analyzed in detail for their 
metabolites and many more active strains are waiting to be explored.  This project encompasses 
many aspects of science, involving microbiological methods for the selective isolation of 
actinomycetes and subsequent cultivation of isolated s rains in appropriate production mediums 
as well as chemical methods for the bioassay guided fractionation of organic extracts of 
actinomycete cultures and structural determination of the active compounds they produce.   
Isolation of actinomycetes from marine sediments 
 To begin with, the focus of the project was to collect actinomycetes from marine 
sediments.  Sediment samples were treated in order to s lect for actinomycete colonies.  Heat 
treatment (550C, 1 hour) as well as isolation mediums containing complex carbon sources 
(chitin) and the antibiotic cylcohexamide in order to eliminate competing bacteria and fungi were 
used for selective isolation.  Additionally gram staining and analysis of colony morphology were 
done by microbiologists at aaiPharma in order to select and isolate potential actinomycete 
colonies from the highly competitive isolation plate.  Once pure colonies of potential 
actinomycetes were obtained, plates were sent to Accugenix (Newark, DE) for phylogenetic 
analysis using sequence comparisons of the 16S ribosomal subunit.  One disadvantage of 
outsourcing the genetic identification of these marine actinomycete strains, concerns new studies 
giving evidence of physiologically unique actinomycetes isolated exclusively from marine 
sediments.  For example, the unique 16S sequences for the two new obligate marine genera 
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Salinaspora and Marinaspora are likely to not exist in the database used for these analyses and 
those strains with large variations in genetic divergence may in fact belong to these new taxa.  
This is important because it is more likely that novel metabolites with unique chemistries will be 
produced by less common actinomycete species, especially those with adaptations to the marine 
environment.  
Media conditions have been found to be very important in the successful isolation and 
cultivation marine actinomcyetes (Jensen et al 2003).  The salinity of sampling sites should be 
considered when plating sediment samples.  The distribution of genera among sampling sites 
revealed very few actinomycetes in the July 2004 sampling in the Florida Keys.  Interestingly, 
salinity data revealed that these samples originate from a drastically more saline environment 
than other sampling sites.  It could be possible that t e isolation conditions were not optimal and 
increasing the salinity of the media could result in a more accurate depiction of the actinomcyete 
genera represented.   
Isolation and characterization of bioactive metabolites    
Fermentation conditions must also be optimized in order to increase the likelihood of 
isolating new and interesting secondary metabolites.  There are several examples of metabolites 
produced only when conditions specific to the marine e vironment are provided.  Japanese 
researchers have continuously reported on selective metabolite production in media containing 
the brown seaweed Laminaria (Okami et al 1979; Nakamura et al 1977; Takahashi et al 1989).  
Streptomyces malysiensis (isolate 4) was experimentally cultured in a Laminaria containing 
media and found to retain production of the broad spectrum antibiotics produced in a starch, 
yeast and peptone containing media.  Interestingly, the crude extracts from cultures grown in 
Laminaria containing media were found to be much simpler than t ose cultured in more standard 
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nutrient conditions, which could simplify the isolation process.  Natural products are produced in 
low concentrations and continuous cultivation and extraction is required in order to accumulate 
sufficient amounts of material for analysis.  The pr sence of less complex crude extracts and 
subsequent simplification of the purification process without a loss in production of the active 
metabolites could have a tremendous impact on the accumulation of material and should be 
studied further for both Streptomyces malysiensis as well as other actinomycete species.  In 
addition to carbon sources and salinity, parameters such as agitation and hydrostatic pressure 
should also be considered as the production of new m tabolites has been reported by variations 
in these parameters (Okami and Hotta 1988).  
 Although only two strains were chosen for large scale cultivation and analysis, several 
additional actinomycete species isolated from local m rine sediments displayed antimicrobial 
activity in the disc diffusion bioassay.  Extracts from cultures of Streptomyces albidoflavus and 
Micromonospora olivasterospora were active against fungal cultures, whereas extracts from 
cultures of Streptomyces lienomycini and Micromonospora chalcea showed inhibition against 
bacterial test organisms.   Cultures of Streptomyces griseoplanus and Streptomyces griseorubens 
showed broader activity, inhibiting 2-3 test organisms each.  Slight activity against M.smegmatis 
was seen in extracts from cultures of Streptomcyes albus albus and Streptomyces morookaensis.  
Further analysis and determination of these bioactive metabolites is required.  Antimycobacterial 
activity against M.smegmatis displayed by other strains was very slight and not nearly as 
impressive as the activity displayed by extracts of Streptomyces fimicarius.  Additionally, 
Streptomcyes malaysiensis was the only strain that resulted in extracts inhibiting all test 
organisms.  The potency of the two groups of compounds produced by the selected actinomcyete 
strains was not suprising due to the marine origin of these cultures.  These metabolites are most 
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likely used as chemical defenses in the highly competitive ocean environment and as these 
compounds are released they are immediately diluted, requiring high potency in order to have 
any effect (Haefner 2003).   
 The active metabolites produced by Streptomyces malaysiensis showed activity in the 
disc diffusion assay against all test organisms as well as impressive cytotoxic activity against 
murine fibroblast cells.  These metabolites are produced as two active forms presumed to be 
constitutional isomers.  The producing organism has been mass cultured five times resulting in 
18.0 L of culture media that has been extracted and analyzed for the presence of these potent 
antimicrobial compounds.  Only 10% of this material h s been purified by HPLC-UV and crude 
material processed through the gel permeation chromat graphy method (100 mg) is awaiting 
purification.  Pure material will be accumulated and analyzed by extensive NMR and MS studies 
in order to fully characterize the chemical structure of these isomers.  The increased incidence of 
resistant pathogens, which now includes all major bacterial pathogens as well as all classes of 
antibiotic compounds, has stimulated the need for safer, more potent and broader spectrum 
antibiotics (Payne and Tomasz 2004; Barrett 2005).  The metabolites described here may be of 
interest in the development of new antibiotics or may be used for other purposes, as many 
secondary metabolites with antibiotic activity are used for numerous pharmacological purposes, 
including immunosuppressant and anticancer agents (Demain 2000b).    
 The active metabolites produced by Streptomyces fimicarius exhibit selective inhibition 
against Mycobacterium smegmatis.  These compounds were found to be produced as a fmily of 
three related compounds but because purity has not been achieved, it is unclear if one or all of 
these derivatives are responsible for biological activity.  The use of Mycobacterium smegmatis as 
a surrogate test organism for the discovery of anti-tuberculosis agents in this project began in 
 33 
November of 2005.  The antimycobacterial properties of Streptomyces fimicarius were only 
recognized recently and since then this strain has only been mass cultured twice, resulting in 7.2 
L of culture media.  The isolation procedure for these selective M.smegmatis inhibitors is still in 
the developmental stage.  Crude material will continue to be isolated from mass culture of 
Streptomyces fimicarius and a method for the purification of these three products will be 
developed.  As pure material is acquired, extensive NMR and MS studies will be used to 
characterize the structural features as well as bioassay testing to determine relative activity of 
these three metabolites.  Multidrug resistant strains of Mycobacterium tuberculosis continue to 
become dominant and reported tuberculosis cases were in xcess of 8 million last year, resulting 
in over 2 million deaths.  Additionally, of the several hundred natural products discovered with 
antimycobacterial properties none have moved forward in drug development, attributed to low 
yields, relative structural complexity and lack of selectivity (Pauli 2005).  The new 
antimycobacterial metabolites described in this theis show strong and selective inhibition 
against M.smegmatis, making them of high interest in the much needed discovery of TB drugs.   
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CONCLUSION 
 A diverse collection of actinomycetes has been isolated from local marine sediments.  
Cultivation of isolated strains and analysis of organic extracts have revealed many interesting 
biological activities.  Although this project is still in its infancy, preliminary results show marine 
sediments to be a new source of actinomcyete strain with the ability to produce unique 
compounds.  More than 50 actinomycete strains have been isolated and cultivated, 38.5% of 
which show biological activity against one or more test organism.  Two strains (Streptomyces 
malaysiensis and Streptomyces fimicarius) have been mass cultured and analyzed in detail for the 
compounds they produce.  Broad spectrum antimicrobial metabolites were isolated from cultures 
of Streptomyces malaysiensis and a family of antimycobacterial metabolites was isolated from 
cultures of Streptomcyes fimicarius.  Although the structures of these metabolites have not yet 
been determined, they display potent biological activity and appear to contain unique structures.  
This collection of actinomycetes will continue to be explored in search of new and unique 
bioactive substances and has the potential to yielda variety of new and interesting bioactive 
secondary metabolites.      
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INTRODUCTION 
Cyanobacteria are prokaryotic, single celled organisms formerly called blue-green algae.  
These photosynthetic prokaryotes get their name from a unique accessory pigment phycocyanin, 
a bluish phycobilin that gives these organisms their blue-green color (Chorus 2000).  Blooms of 
cyanobacteria are a natural phenomenon and can occur in inland and coastal waters worldwide 
(Reynolds and Walsby 1975).  Cyanobacteria have the ability to produce a variety of secondary 
metabolites, many of which are unique peptide-based compounds.  In most instances, the 
ecological role of such secondary metabolites is unclear, though some of these peptide 
compounds are extremely potent toxins which can kill a variety of organisms.  Consequently, it 
has been suggested that the production of intracellular toxins discourages grazing and 
consumption by herbivores, though other biological roles could exist.  Regardless of the 
physiological basis of toxin production, the poisonous health effects reported among higher 
invertebrates and vertebrate aquatic and terrestrial biota constitute serious environmental and 
economic problems in both coastal and marine habitats (Paerl 1988).   Such cyanobacterial 
blooms have been predicted to proliferate in both size and duration due to increased 
eutrophication of water bodies worldwide by pollution with nutrients from agriculture and 
domestic waste water (Carmichael 1992).   
Microcystis is the most common bloom-forming genus of cyanobacteria (Carmichael 
1989).  Microcystis blooms commonly produce liver toxins, known as microcystins.  The 
microcystins are cyclic heptapeptides consisting of (2S,3S, 8S, 9S)-3-amino-9-methoxy-2,6,8-
trimethyl-10-phenyl-deca-4,6-dienoic acid (β-amino acid referred to as Adda) connected to D-
glutamic acid (D-Glu), N-methyldehydroalanine (Mdha) and D-alanine (D-Ala) followed by two 
variable L-amino acids X and Z linked through a D-methylaspartic acid (D-MeAsp) (Kubwabo 
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2005).  Adda, a C-20 β-amino acid residue unique to cyanobacterial metabolites, contains a 
conjugated diene responsible for the UV chromophore of microcystins which absorbs at 238 nm 
(McElhiney and Lawton 2005).  The toxicity of microystins also appears to be associated with 
this Adda residue (Harada et al 1990).  Substitutions f variable L-amino acids at positions 2 and 
4 give rise to more than 20 primary analogs (Figure 10).  The most common and most toxic 
microcystin contains leucine (L) and arginine (R) at these positions, and is designated 
microcystin-LR (Sivonen and Jones 1999).  Numerous additional analogues result from various 
methylation and demethylation patterns, as well as modifications in the Adda component 
(Zurawell et al. 2005).  More than 70 analogs of microcystins have been described; these 
variations have consequences for the chemical properties, geometry, and conformation of the 
molecule and result in pronounced differences in toxicity as well as hydrophobic/hydrophilic 
properties (Chorus 2000).  Microcystins cannot cross cell membranes, but can be actively 
transported by the bile acid transporter mechanism and hence preferentially attack the liver.  The 
toxic effects of microcystins are due to their inhibition of eukaryotic protein phosphatases 1 and 
2a (PP1 and PP2a).  PP1 and PP2a are major factors in he control of several cellular processes 
including carbohydrate metabolism, muscle contraction, and cell division.  As these toxins are 
preferentially taken up by hepatocytes (the functional cells of the liver), they are responsible for 
acute liver failure as well as tumor promotion (Chorus 2000, Lawton and Codd 1991).  
Increased concern about the acute toxic effects of microcystins has led to the World 
Health Organization to establish a drinking water guideline level of 1 µg/ L for MCLR 
(Humpage et al. 2000).  No analytical standards for mic ocystins exist and only few variants are 
available commercially (McElhiney and Lawton 2005).  Rapid detection methods are needed to 
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Figure 10.  Microcystin structure and some structural variants 
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test for the presence of these toxins in water supplies, requiring a steady supply of reference 
material (Carmichael 1981, Lawton and Codd 1991). The North Carolina Department of Health 
and Human Services (NCDHHS) requires a reliable source of purified microcystin-LR as a 
reference standard for the development of methods to tes  environmental samples.  The purpose 
of this section of the thesis was to develop a method for the isolation and purification of 
quantities (2-10 mg) of microcystin-LR from laboratory cultures of Microcystis aeruginosa. 
In addition to the hepatotoxic microcystins, several other families of non-hepatotoxic 
peptides have been identified from Microcystis, as well as other genera of cyanobacteria 
(Namikoshi and Rinehart 1996).  The majority of peptides that have been isolated from 
Microcystis can be grouped into six classes according to theirstructural features (see Table 3 and 
Figure 11 for representative examples) (Welker et al. 2004a).   Aeruginosins and microginins are 
linear polypeptides containing 3-6 amino acids.  These cyanopeptides are protease inhibitors, 
responsible for such activities as thrombin inhibition and angiotensin converting enzyme (ACE) 
inhibition.  Anabaenopeptins, another class of cyanopeptide protease inhibitors, are cyclic 
hexapeptides.  Microcystins, as mentioned, are cyclic heptapeptide hepatotoxins containing a 
unique C-20 β-amino acid known as Adda.  Cyanopeptolins are cycli  polypeptides possessing 
various enzyme inhibitory activities, including tyrosinase and plasmin inhibition.  Microviridins 
are large multicyclic peptides which also possess inhib tory activity towards proteases such as 
trypsin and chemotrypsin.  Similar to the Adda residue in microcystins, several other classes of 
cyanopeptides contain unusual β-amino acids that are unique to each class of cyanopeptide and 
aid in their identification by the presence of indicat ve fragment ions in mass spectrometry 
(Kubwabo et al. 2005; Welker et al. 2004b).  The protease inhibitory activity of these peptides 
provides no known function for the producing organism, but is most likely directed against 
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Peptide class General 
structure 
Amino 
acids 
Known 
variants 
Characteristics Taxonomic distribution 
Aeruginosins 
 
 
 
 
Microginins 
 
 
Anabaenopeptins 
 
 
Cyanopeptolins 
 
 
 
Microcystins 
 
 
Microviridins 
Linear 
 
 
 
 
Linear 
 
 
Cyclic 
 
 
Cyclic 
 
 
 
Cyclic 
 
 
Multicyclic 
4 
 
 
 
 
3 to 6 
 
 
6 
 
 
7 to 9 
 
 
 
7 
 
 
14 
19 
 
 
 
 
38 
 
 
29 
 
 
68 
 
 
 
90 
 
 
10 
2-Carboxy-6-hydroxy-
octahydroindole (Choi); Arg 
derivative at C-terminus; 
hydroxyphenyllactic acid 
(Hpla) at N-terminus 
Modified deacnoic or 
octanoic acid at N-terminus, 
Tyr at C-terminus 
Lys with secondary amino 
bond; ureido bond from ring 
(Lys) to side chain 
3-Amino-6-
hydroxypiperidone (Ahp); 
ester bond of Thr in ring; 
side chain of variable length 
3-amino-9-methoxy-2,6,8-
trimethyl-10-phenyldeca-
4,6-dienoic acid (Adda) 
Secondary amino and ester 
bonds of Lys, Ser, Thr; tri-or 
tetracyclic peptide 
Microcystis, Planktothrix, 
Anabeana 
 
 
 
Microcystis, Planktothrix 
 
 
Microcystis, Planktothrix, 
Anabeana 
 
Microcystis, Planktothrix, 
Anabeana, Nostoc, 
Lyngbya 
 
Microcystis, Planktothrix,              
Anabeana, Nostoc 
 
Microcystis, Planktothrix,  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Structural characteristics of six classes of cyanobacteria peptides (Welker et al. 2000) 
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Figure 11.  Representative structures of 6 major cyanopeptide classes 
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digestive proteases of crustacean grazers (Agrawal et al 2005).   
In a 5 year study at the University of Hawaii and supported by the National Cancer 
Institute and the Eli Lilly Research Laboratories, the discovery rate for bioactive compounds 
within cyanobacteria for field collected and then laboratory grown cultures was about 7%, very 
comparable to other groups of microorganisms.  However in contrast to the other groups tested, 
cyanobacteria had a significantly lower rediscovery rate of known bioactive compounds.   Thus, 
cyanobacteria have the potential to provide useful pharmacological substances that do not 
duplicate structures already discovered from other natural sources (Carmichael 1992).    
During the large-scale growth, isolation and purificat on of MCLR from laboratory cultures of 
Microcystis aeruginosa (UTEX LB2385), some other peptide metabolites of interest were 
isolated and characterized.    These peptides were found to contain structural features consistent 
with the microginin class of cyanopeptide metabolites.  The first microginin was described in 
1993 and since then more than 20 derivatives have been described (Okino et al.1993).  These 
cyanopeptides contain 4-6 amino acids, usually including a modified β-amino acid as well as a 
C-terminus tyrosine.  The structural features as well as biological activities of known structural 
variants can be seen in Table 4.  Previously characterized microginins have shown angiotensin 
converting enzyme (ACE) inhibition as well as leucine aminopeptidase M (APM) inhibition, 
making them potent vasodilators.  Consequently, these compounds are of interest as lead 
compounds in the discovery of novel antihypertensive agents as well as treatments for congestive 
heart failure.  This thesis describes the isolation and structural determination of five new 
microginin peptides containing previously undescribed structural features including the amino 
acid methionine, various methylation on the modifie octanoic acid chain and the first tripeptide 
microginin.  Biological activity of these new microginin congeners has not yet been determined.   
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Cyanobacterium Microginin R1 R2 R3 R4 R5 (R6) Activity References 
Microcystis 
aeruginosa  
NIES-100 
microginin Ahda Ala Val MeTyr Tyr ace i,  
apm i 
Okino et al., 
1993 
Ishida et al., 
2000 
Microcystis 
aeruginosa  
TAC-51 
microginin 51-A 
microginin 51-B 
Ahda 
MeAhda 
Tyr 
Tyr 
MeVal 
MeVal 
MeTyr 
MeTyr 
Pro (Tyr) 
Pro (Tyr) 
ace i 
 
Ishida et al., 
2000 
Microcystis 
aeruginosa 
 TAC-91 
microginin 91-A 
microginin 91-B 
microginin 91-C 
microginin 91-D 
microginin 91-E 
Ahda-Cl 
Ahda-Cl2 
Ahda 
Ahda-Cl 
Ahda-Cl2 
Ile 
Ile 
Ile 
Ile 
Ile 
MeLeu 
MeLeu 
MeLeu 
MeLeu 
MeLeu 
Pro 
Pro 
Pro 
Pro 
Pro 
 
 
Tyr 
Tyr 
Tyr 
 
 
apm i 
apm i 
apm i 
Ishida et al., 
2000 
Microcystis 
aeruginosa  
NIES-99 
microginin 99-A 
microginin 99-B 
Ahda-Cl 
Ahda-Cl2 
Tyr 
Tyr 
Leu 
Leu 
MeTyr 
MeTyr 
Pro 
Pro 
 Ishida et al., 
1998 
Microcystis 
aeruginosa 
 NIES-299 
microginin 299-A 
microginin 299-B 
Ahda-Cl 
Ahda-Cl2 
Val 
Val 
MeVal 
MeVal 
MeTyr 
MeTyr 
Pro (Tyr) 
Pro (Tyr) 
lap i 
lap i 
Ishida et al., 
1997 
Microcystis 
aeruginosa  
NIES-299 
microginin 299-C 
microginin 299-D 
Ahda 
Ahda-Cl2 
Val 
Val 
MeVal 
MeVal 
MeTyr 
MeTyr 
Pro (Tyr) lap i 
lap i 
Ishida et al., 
1998 
Microcystis 
aeruginosa  
NIES-478 
microginin 478 MeAhda Val MeVal MeTyr Tyr ace i,  
apm i 
Ishida et al., 
2000 
Microcystis sp. 
(bloom) 
microginin FR1 Ahda Ala MeLeu Tyr Tyr ace i,  
apm i 
Neumann et 
al., 1997 
Microcystis 
aeruginosa (bloom) 
microginin SD755 MeAhoa Val MeIle MeTyr Tyr apn i Reshef & 
Carmeli, 
2001 
water bloom 
 
water bloom 
microginin T1 
 
microginin T2 
Ahda-Cl 
 
Ahda 
Ala 
 
Ala 
Pro 
 
Pro 
Tyr 
 
Tyr 
Tyr 
 
Tyr 
ace i, lap i 
ace i, lap i 
Kodani et 
al., 1999 
Nostoc sp. (bloom) Nostoginin BN578 
Nostoginin BN471 
Ahoa 
Ahoa 
Val 
Val 
NMeIle 
NMeIle 
NMeTyr 
NMeTyr 
Tyr  Pluotmo and 
Carmeli, 
2002 
Oscillatoria agardhii  
NIES-610 
Oscillaginin A 
Oscillaginin B 
Ahda-Cl 
Ahda 
Ser 
Ser 
NMeVal 
NMeVal 
Hty 
Hty 
  Sano and 
Kaya, 1997 
 
 
a Order of the residues is from the N-terminus to the C-terminus.  Ahda = 3-amino-2-hydroxydecanoic acid; Ahda-Cl(2) = 10-
(di)chloro-3-amino-2-hydroxydecanoic acid; MeAhda = N-methyl-Ahda; MeAhoa = N-methyl-3-amino-2-hydroxycanoic acid; 
MeVal = N-methyl-valine; MeTyr = N-methyl-tyrosine 
 
 
b Activities reported in the references. ace = angiotensin-converting enzyme; apm = aminopeptidase M; apn = bovine 
aminopeptidase N; lap = leucine aminopeptidase; i= inhibition 
 
 
 
 
Table 4. Structure, origin, and activity of microginins isolated from freshwater cyanobacteria 
 (Welker et al. 2004a).  
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EXPERIMENTAL 
Culture Methods 
 Microcystis aeruginosa cells (UTEX LB2385) were obtained from the University of 
Texas Culture Collection and grown at CMS in B3N media in a 14/10 light-dark cycle for 4 
weeks before harvest.   
Chromatography Methods 
 Stationary phases used in open column chromatography were Supelco ENVI-18 (reversed 
phase) and Sephadex LH-20.  High performance liquid chromatography (HPLC) stationary 
phases used were Waters SunFire C18, Supelco Discovery Amide C16, and Waters Symmetry 
Shield RPC18.   Solvents used were HPLC grade methanol and acetonitrile purchased from 
Fisher Scientific and trifluoroacetic acid (TFA) purchased from Alfa Aesar.  Water was purified 
by Labconco Water Pro Plus water deionization system.  Preparative HPLC was performed using 
Waters pumps (515), automated gradient controller, and dual wavelength detector (2487).     
Analytical Methods 
 ESI-MS data was obtained using a Hewlett Packard Se ies 1100 HPLC connected to a 
Waters Micromass ZQ with electrospray ionization (capillary voltage 3.0 kV; cone voltages 
30V/50 V; source temperature 140; desolvation temperature 350; cone gas flow 100; desolvation 
gas flow 600).  All samples were run in positive ion mode with a mass range of 100-1400 and a 
scan time of 0.5 sec.  Accurate molecular weight data was obtained using a quadrapole time of 
flight mass spectrometer (Applied Bioscience-MDS Sciex QStar XL).  Daughter ion experiments 
were performed using an ion trap mass spectrometer (Applied Bioscience-MDS-Sciex QTrap).   
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 Nuclear magnetic resonance (NMR) experiments were p formed on a Bruker Avance 
500 MHz NMR at 293.9 K.  Probes used include a 5.0 mm BBO, 5.0 mm TXI, and 1 mm TXI.  
NMR solvents (d6-DMSO, d4-methanol) were purchased from Cambridge Isotope Laboratories. 
Harvest and Extraction  
 Cultures were filtered (Whatman GF/A filter paper) and collected cells were frozen until 
extraction (-200C).   Filter paper discs containing cells were extracted with 80% methanol 
overnight (800 ml).  This procedure was repeated, the extracts combined and partitioned against 
hexane to remove any pigments and non-polar compounds.  The hexane layer was discarded and 
the aqueous methanol layer was dried and weighed.  
Isolation and purification of cyanopeptides (Figure 12) 
The aqueous methanol extract was resuspended in 20% methanol (2 ml), applied to a 
Sep-Pak cartridge (10 g/60 ml) and eluted with a methanol step gradient (20-100% MeOH).  
Compounds of interest eluted in the 40% and 60% methanol fractions and were combined and 
applied to an LH-20 column (19 cm x 1 cm).  The column was eluted with two column volumes 
of 100% methanol (50 mL), and fractions (1 ml) were collected using a RediSep fraction 
collector.   Fractions were analyzed for the presence of microcystin-LR using HPLC-UV in 
comparison to the retention time of an MCLR standard purchased from Sigma (Vydac RPC18, 2 
x 250 mm; 2-100% aqueous acetonitrile / 0.05% TFA over 10 min; flow rate 1 ml/min; detection 
238 and 214 nm; MCLR standard rt = 8.5 min.)  Microcystin- and microginin-containing 
fractions were combined and subjected to preparative HPLC-UV using a Waters SunFire C18 
column (19 x 250 mm; 40-100% aqueous methanol / 0.05% TFA over 30 min; flow rate 10 
ml/min; detection 238 and 214 nm).  Five peaks ( 5 rt 16.1 min, 3 rt 18.0 min., 1, 2, 4 rt 20.0 min., 
6,7 rt 22.0 min., and 8 rt 23.0 min.) were collected and analyzed by HPLC-ESIM .  Final 
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M. aeruginosa cells extracted with 80% Methanol
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20% MeOH                  40% MeOH                    60% MeOH                80% MeOH             100% MeOH
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1 505-15
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                                                                                                            m/z 996, 13.0min.
HPLC-UV
Supelco Discovery Amide C16 column
20-50% aqueous ACN +0.05% TFA over 16.7 min.
 
 
 
 
 
Figure 12. Fractionation scheme for the isolation of peptides from organic extracts of Microcystis 
aeruginosa 
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purification by HPLC-UV of peaks was subsequently performed using a Supelco Discovery 
Amide C16 column (4.6 x 250 mm, 20-50% acetonitrile/0.05% TFA over 16.7 min; flow rate 1.0 
ml/min), yielding purified 5 rt 6.2 min, 3 rt 8.0 min., 1 rt 10.5 min, 7 rt 12.2 min., and 6 rt 13.0 
min.  These purified compounds were analyzed by NMR using d6-DMSO and d4-methanol.  
LC/MS analysis was performed using a Waters Symmetry Shield RPC18 column (2.1 x 150 mm, 
3.5 µm; 20-80% acetonitrile/0.05%TFA over 30 min; flow rate 0.2 ml/min). Additional 
biological and analytical data for each compound are reported below. 
Microginin 674(1): UV λmax (MeOH) 224, 276 nm; ESIMS m/z 675 [M+H]+ 
(fragmentation data in Figure 17); high resolution MS m/z 675.3253 (C34H50N4O8S); 
1H and 13C-
NMR see Table 5. 1H, TOCSY and HSQC NMR spectrum see Appendices D-F 
Microginin 511(2): UV λmax (MeOH) 224, 276 nm; ESIMS m/z 512 [M+H]+; high 
resolution MS m/z 511.8786 (C25H41N3O6S). 
Microginin 690(3): UV λmax (MeOH) 224, 276 nm; ESIMS m/z 691 [M+H]+ 
(fragmentation data in Figure 18); high resolution MS m/z 691.3205 (C34H50N4O9S); 
1H and 13C-
NMR see Table 6.  1H, TOCSY and HSQC NMR spectrum see Appendices G-I 
Microginin 704(4):  UV λmax (MeOH) 224, 276 nm; ESIMS m/z 705 [M+H]+; high 
resolution MS m/z 705.1430 (C35H51N4O9S). 
Microginin 527(5): UV λmax (MeOH) 224, 276 nm; ESIMS m/z 528 [M+H]+; high 
resolution MS m/z 527.8912 (C25H41N3O7S). 
Microcystin-LR(6): UV λmax (MeOH) 238 nm; ESIMS m/z 996 [M+H]+ (fragmentation 
data in Figure 14); high resolution MS m/z 995.5469 (C49H73N10O12) 
[D-Asp3] Microcystin-LR(7): UV λmax (MeOH) 238 nm; ESIMS m/z 982 [M+H]+; high 
resolution MS m/z 981.7139 (C48H71N10O12). 
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Microcystin-L(NMe)R (8): UV λmax (MeOH) 238 nm; ESIMS m/z 1010 [M+H]+; high 
resolution MS m/z 1009.7587 (C50H75N10O12) 
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Table 5. Assignment of  1H and 13C NMR data for microginin 674 (1) in d6-DMSO 
 
 Position 1H 13C 
2 O-Me, 3-N,N-dimethyl 
amino-octanoic acid 
1 
2 
2-OMe 
3 
3-NMe (2) 
4 
5 
6 
7 
8 
 
4.0 
3.18 
3.01 
2.63 
1.41 
1.24 
1.22 
1.35 
.85 
171.5 
71 
49 
54 
32.5 
26 
30 
30 
23 
15 
Met (O) 1 
2 
3 
4 
5 
NH 
 
5.0 
2.3 
1.8 
2.0 
8.4 
169.5 
57 
31 
29.5 
16 
 
Tyrosine 1 
2 
3 
 
4 
5, 9 
6, 8 
7 
7-OH 
NH 
 
4.3 
2.95 
2.85 
 
7.02 
6.64 
 
9.2 
7.83 
172.5 
55 
37 
 
 
131 
116 
158 
Tyrosine 1 
2 
3 
 
4 
5, 9 
6, 8 
7 
7-OH 
NH 
 
4.7 
2.87 
2.77 
 
7.0 
6.62 
 
9.2 
8.23 
174 
52 
37 
 
 
131 
115 
158 
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Table 6. Assignment of  1H and 13C NMR data for microginin 690 (3) in d6-DMSO 
 Position 1H 13C 
2 O-Me, 3-N,N-dimethyl 
amino-octanoic acid 
1 
2 
2-OMe 
3 
3-NMe (2) 
4 
5 
6 
7 
8 
 
4.0 
3.18 
3.01 
2.63 
1.41 
1.24 
1.22 
1.35 
.85 
171.5 
71 
49 
54 
32.5 
26 
30 
30 
23 
15 
Met (O) 1 
2 
3 
4 
5 
NH 
 
5.0 
2.4 
2.55 
2.5 
8.4 
169.5 
57 
30 
51 
39 
 
Tyrosine 1 
2 
3 
 
4 
5, 9 
6, 8 
7 
7-OH 
NH 
 
4.3 
2.95 
2.85 
 
7.02 
6.64 
 
9.2 
7.83 
172.5 
55 
37 
 
 
131 
116 
158 
Tyrosine 1 
2 
3 
 
4 
5, 9 
6, 8 
7 
7-OH 
NH 
 
4.7 
2.87 
2.77 
 
7.0 
6.62 
 
9.2 
8.23 
174 
52 
37 
 
 
131 
115 
158 
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RESULTS 
Isolation and Purification of Microcystin-LR and Derivatives 
  Compound 6 (m/z 996, [M+H]+)was isolated as a white powder.  The UV data (λmax 
238 nm, Figure 9) as well as MS data (Figure 10) confirmed the identity of this peak as 
microcystin-LR.  The desmethyl derivative [Asp3] microcystin-LR (7, m/z 982, [M+H]+) as well 
as the N-methyl derivative microcystin-L(NMe)R (8, m/z 1010, [M+H]+) were also isolated by 
this procedure.  Location of these desmethyl and methyl variants was established by comparison 
of the ESIMS fragment ions with those assigned in the literature.  For example, in determination 
of the desmethyl variant, analysis of the ESIMS data revealed that the fragment ion of m/z 286 
corresponding to [H+Arg-MeAsp]+ as well as the fragment ion of m/z 399 corresponding to 
[H+Leu-MeAsp-Arg]+ observed in 6 were both 14 Da less in the ESIMS of 7.  The fragment ion 
of m/z 174 corresponding to [Arg-NH2-2H]
+ was seen in the spectra of both compounds.  These 
data indicate that the MeAsp (residue 3) in 6 has been replaced by Asp in 7 resulting in [Asp3] 
microcystin-LR.  In determination of the methylated derivative, the characteristic ESIMS 
fragment ions at m/z 553 ([H+Mdha+Ala+Leu+MeAsp+Arg]+), m/z 470 
([H+Ala+Leu+MeAsp+Arg]+), m/z 399 ([H+Leu-MeAsp-Arg]+ ) and m/z 268 
([H+Mdha+Ala+Leu]+) in the spectra of 6, were all 14 Da more in the HRMS of 8. However, the 
fragment ion of m/z 599 ([H+MeAsp+Arg+Adda]+) was unchanged, indicating that this 
methylation existed on the leucine residue (residue 2).  1H NMR analysis of 8 revealed a singlet 
at δ 2.62 not seen in the 1H spectra of 6, indicating that 8 contained an NMe-Leu in place of Leu 
in residue 2.          
Isolation and Structural Determination of Microginin Peptides 
Compound 1 (m/z 674, [M+H]+) was isolated as a white powder.  The HRMS and NMR    
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Figure 13. UV data for microcystin-LR 
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Figure 14. ESIMS of purified microcystin-LR 
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data revealed a molecular formula of C34H50N4O9S, requiring 12 degrees of saturation.  Four 
carbonyl carbons revealed by the 13C NMR data as well the presence of four isolated spin
systems in the TOCSY and COSY NMR spectra confirmed th  tetrapeptide nature of this 
compound (Table 5).  The UV data (λmax 224, 276 nm) (Figure 16) indicated the presence of an 
aromatic amino acid.  Indeed, the ESI-MS data (Figure 17) revealed a strong fragment ion at 
[M+H -180]+ (m/z 494) consistent with a C-terminus tyrosine moiety.  Another fragment ion at 
m/z 327, characterized as the loss of a di-tyrosine C-t rminus, revealed a second tyrosine residue 
adjacent to the C-terminal tyrosine.  The presence of two tyrosine residues was confirmed by 
NMR data (Table 5).  The two rings from the tyrosine residues and the four carbonyl carbons 
satisfied all the degrees of saturation.  The fragment ion at m/z 128 suggested an N-terminus α-
amino-β-hydroxy decanoic acid (Ahda), common in microginin peptides.  1H and TOCSY NMR 
data was consistent with a modified β-amino acid; however none of the observed amide 
resonances correlated to resonances in this chain.  HSQC data revealed two methyl resonances at 
δ 2.63 correlated to a carbon resonance at δ 32.5, indicating two methyl groups attached to 
nitrogen.  It was therefore determined that the β-amino acid was a 3-N, N-dimethyl amino-
octanoic acid, instead of Ahda.   Furthermore, the methyl resonance at δ3.18 which correlated 
with a carbon at δ 49 was consistent with a methyl attached to oxygen.  This N-terminus moiety 
was finally determined to be 2 O-methyl, 3-N, N-dimethyl amino-octanoic acid. A moiety 
corresponding to 147 Da remained unaccounted for.  The HSQC spectra of 1 revealed a 
correlation between a proton at δ 2.0 and a carbon at δ 16, consistent with a methyl group 
attached to sulfur.  Analysis of the TOCSY and COSY spectra revealed a spin system correlating 
the amide resonance at δ 8.4 with the methine resonance at δ 5.0, which in turn was correlated to 
the resonances of δ 2.3, 2.0, and 1.8.  It was therefore determined that t e unknown residue was a  
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Figure 16. UV data for microginins (1-5) 
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Figure 17. ESIMS data and proposed fragmentation of microginin 674 (1) 
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Figure 18. ESIMS data and proposed fragmentation of microginin 690 (3) 
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Figure 19. Microginin peptides isolated from Microcystis aeruginosa (UTEX LB2385) 
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methionine.  NMR analysis of compound 3 (m/z 691, [M+H]+)(Table 6), showed the di-tyrosine 
C-terminus and N-terminus modified octanoic acid to be unchanged.  The HSQC spectra of 3
revealed that the methyl group resonances attached to sulfur in methionine had moved downfield 
(1H and 13C resonances at δ 2.5 and δ 39, respectively).  Furthermore, an intense fragment ion of 
[M-64]+  in the ESI-MS of 3 was consistent with a loss of a CH3SOH entity, previously not seen 
in the ESI-MS of 1 (Figure 18).  It was therefore determined that 3 was the methionine sulfoxide 
derivative of 1.   
Compound 2 (m/z 511, [M+H]+)was also isolated as a white powder.  This compound 
had the same UV absorbance as compound 1 and shared the diagnostic fragment ion of m/z 128 
but had a molecular weight of 511.27 Da, 163 Da less than 1. NMR studies confirmed the 
presence of the modified octanoic acid chain as well as the methionine of 1, however 2 contained 
a single C-terminus tyrosine.  Compound 5 (m/z 528, [M+H]+), shared the UV absorbance of 2 
and NMR shifts corresponding to the modified octanoic chain and a single tyrosine residue.  
HSQC correlations revealed the same downfield shiftof the methionine resonances as seen in 3 
compared to 1.  5 was therefore determined to be the methionine sulfoxide derivative of 2.  
Compound 4 (m/z 705, [M+H]+) had a parent ion 14 Da more than compound 3.  NMR analysis 
revealed the same spectra of 3, with the exception of a new 1H shift at δ 2.55, consistent with N-
methylation.  ESIMS analysis of 4 showed similar fragmentation to 3 however the fragment ion 
at m/z 510, corresponding to the loss of the terminal tyrosine residue was seen in both spectra.  4 
was determined to have the same structure of 3 with the exception of an N-methyl tyrosine at the 
C-terminus. 
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DISCUSSION 
Isolation and purification of microcystins 
Concern regarding the presence of microcystins in drinking water lakes and reservoirs 
has resulted in the need for reliable methods for their detection and accurate quantification.  One 
of the main difficulties associated with the detection of these toxins is the lack of standardized 
reference material.  Of the more than 70 variants of microcystins that have now been reported, 
only a few are commercially available and although many studies refer to commercially supplied 
microcystins as standards, none are actually sold as such and the amounts provided cannot be 
guaranteed (McElhiney and Lawton 2005).  Purified microcystins are utilized in a range of 
research applications including toxicological and biochemical studies, development of detection 
systems and the investigation of water treatment stra egies (Lawton and Edwards 2001).   
 In a typical microcystin purification process, cyanobacterial cells are extracted, the 
resultant extract concentrated and the microcystins purified by a range of sample separation 
techniques, though the number of steps and methods employed vary greatly.  A recent study by 
Lawton and Edwards (2001) examined the optimal methods for purification of microcystins. 
Aqueous methanol (50-80% ) was found to be most suitable for the extraction of microcystins, 
typically followed by reversed phase flash chromatography.  Size exclusion chromatography, 
usually Sephadex LH-20, was also found to be useful in the isolation of microcystins for the 
removal of pigments and large interfering molecules.  For HPLC chromatography, trifluoroacetic 
acid is often used as a modifier in the mobile phase.  The addition of TFA not only maintains a 
low pH in order to protonate carboxylic acid groups in peptides, it also acts as an ion pairing 
agent, increasing the retention of poorly retained p ptides.  Analytes with minor structural 
differences often overlap in HPLC separations, especially desmethyl variants.  Amide C16 
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stationary phase was found to be optimal for the separation of desmethylated toxins from their 
non-desmethylated forms (Spoof et al 2001).       
Microcystins are frequently isolated from both field collected and laboratory cultured 
cyanobacteria.  Although field samples have the advantage of biomass availability with no initial 
investment of time required for the preparation of bulk cultures, these field samples are rarely 
composed only of cyanobacteria, let alone a single species, making it difficult to determine 
which organisms is responsible for metabolite production.  In contrast, laboratory cultured 
cyanobacteria display consistent metabolic profiles and many are maintained in culture 
collections providing a reliable and renewable source.  Additionally, extracts from laboratory 
harvested cells tend to be less complex, making purification of microcystins simpler (Lawton and 
Edwards 2001).  
In the course of this work, the method developed for the isolation and purification of 
microcystin-LR has been automated and optimized.  The first fractionation step, initially 
performed using a C18 reversed phase SepPak column, has been automated to involve the use of 
a CombiFlash companion.  This automated solid phase extraction system decreases time and 
effort by the ability to detect compounds at specifi d wavelengths but also by automated mixing 
of mobile phases.  Additionally in this method the pr parative HPLC stage has been scaled up.  
The same stationary phase is utilized in this scaled up method, but a larger size column (19 x 250 
mm) is used, allowing up to 1 mg of material to be loaded and separated at a time.     
Microcystin-LR and its derivatives have been isolated from collected cells of more than 
300 L of M. aeruginosa cultures.  In the final stage of purification the microcystin-LR still 
contains traces of [Asp3]microcystin-LR which can be separated using an amide C16 HPLC 
column.  So far not all of this material has been purified by Amide C16 HPLC but to date a total 
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of 4.6 mg of microcystin-LR has been obtained and half of this (2.3 mg) was sent to the 
NCDHHS.  More than 15 mg of microcystin-LR still containing the desmethyl variant are 
awaiting purification and an additional 9 mg of micro ystin-LR is expected to be recovered from 
this.   
Isolation and structure determination of microginin peptides 
 Of the more than 20 microginin congeners already described, the five new peptides 
described here are the only variants that contain a methionine residue.  Additionally, these 
derivatives contain a unique N-terminus β-amino acid with a higher degree of methylation than 
any previously described congener.  It was fortunate that the indicative fragment ion of m/z 128 
was still a product of this unusual β-amino acid.  Without this characteristic fragment, the 
identification of these metabolites as being microginin derivatives as well as subsequent 
structural determination would have been more difficult.   
The existence of the methionine sulfoxide is most likely an artifact of the isolation 
process and not a product of biosynthesis.  Initial analysis revealed one major peak (m/z 691) 
eluting before the microcystins, with the other microginin derivatives being produced in much 
lower concentrations.  However, extracts that were analyzed more rapidly contained two major 
peaks eluting before the microcystins (m/z 675 and m/z 691) as well as the other microginin 
derivatives still present in low concentrations.  As these compounds were found to be related by 
the existence of common fragment ions and UV absorbance, the most abundant derivative (m/z 
691) was chosen for analysis of structural features.  Structural determination of the methionine 
sulfoxide (m/z 691) microginin derivative was difficult due to the doubling and tripling of 1H 
and 13C NMR signals.  This phenomenon was resolved when t o her major peak (m/z 674), the 
non-sulfoxide congener, was analyzed by NMR.  The NMR data for the non-sulfoxide 
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tetrapeptide revealed a much cleaner spectrum and adistinctive 1H-13C correlation that indicated 
the presence of a sulfur atom (δ 2.0, δ 16).  Until the presence of a sulfur atom was considered, 
required double bond equivalence made identification of the unknown amino acid extremely 
difficult.   The presence of fragment ions representing the loss of 64 Da, later determined to be 
due to a loss of CH3SOH, as well as the doubling and tripling of NMR signals could not be 
explained until this methionine residue was identified.  Other methionine sulfoxide containing 
metabolites from cyanobacteria have been reported and problems in structural determination due 
to the doubling and tripling of NMR signals were also described.  Dendroamides are a family of 
cyclic hexapeptides isolated from the cyanobacterium Stigonema dendroideum.  These 
cyanopeptides exhibit multidrug resistance reversing activity, making them of interest as 
treatments for multidrug resistant tumors.  Dendroamide B contains a methionine residue and 
dendroamide C is the methionine sulfoxide form of den roamide B.  The 1H and 13C NMR 
signals of dendroamide C were found to be doubled, suggesting that the compound actually 
exists as a mixture of R and S sulfoxides (Ogino et al 1996).  Symplostatin 2, a cytotoxic cyclic 
depsipeptide containing a methionine sulfoxide residue, was isolated from the marine 
cyanobacterium Symploca hydnoides.  Once again 1H and 13C NMR signals were found to be 
tripled and this was assigned to the presence of a sulfone conformer in addition to the R and S 
sulfoxides (Harrigan et al. 1999).  Almost all of the methionine sulfoxide signals of 3, 4 and 5 
were doubled or tripled, suggesting that these derivatives exist as both R- and S- forms as well as 
the sulfone conformer.  The sulfone conformer in these new microginin derivatives is indicated 
by the presence of a [M+Na+16]+ fragment in the ESIMS.  The ratios of the extra NMR signals 
reveal that the R and S sulfoxides exist in different concentrations, however until separation of 
these conformers is achieved, the dominant form can not be determined.    
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In addition to the unique methionine residue and high degree of methylation on the 
octanoic acid chain, this is the first report of tripeptide microginin derivatives.  These smaller 
derivatives are produced in much lower quantities than the tetrapeptide methionine containing 
congeners, however continuous isolation and purificat on will accumulate sufficient amounts for 
activity testing.      
Numerous microginin analogs have shown angiotensin converting enzyme (ACE) 
inhibition as well as aminopeptidase M (APM) inhibition as seen in Table 2.  It is not clear how 
the presence of a methionine residue, the size of the tripeptide derivatives or the methylation of 
the N-terminus will affect activity.  Structure activity relationships have shown that the 
dityrosine C-terminal structure is important for ACE inhibition.  Additionally, tetrapeptide 
microginins were found to be more active than pentapeptide microginins and fragments thereof 
(Ishida et al. 2000).  Although biological activity has not yet been determined in these 
microginin derivatives, both the proven track record f these peptides for vasodilative properties 
as well as structure activity relationships make bioactivity of these new congeners probable.  
ACE inhibitors are one of the most effective treatments for hypertension and congestive heart 
failure.  Additionally, APM inhibitory activity makes the vasodilatory activity of these peptides 
two-fold. Consequently, compounds exhibiting dual APM/ACE inhibitory activity, like 
microginins, might prove invaluable as novel vasodilative therapies (Ishida et al. 2000).    
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CONCLUSION 
 Microcystis aeruginosa (UTEX LB2385) was mass cultured and analyzed for the 
presence of toxic peptides.  During the isolation and purification of the heptapeptide hepatotoxin 
microcystin-LR, other unrelated peptide metabolites w re found and characterized.  These new 
peptide metabolites were determined to be tri- and tetrapeptide microginin congeners with 
unique structural features including a methionine residue and a highly methylated N-terminus β-
amino acid.  Cyanobacteria are routinely analyzed for the production of toxins but are rarely 
studied for the production of new and interesting metabolites, however increased concern 
regarding the presence of producing species in drinking water lakes and reservoirs has prompted 
new studies of cyanobacterial metabolites resulting in the isolation of new and interesting 
bioactive metabolites, particularly peptide based compounds with enzyme inhibitory activity.  
Cyanobacteria are now recognized as an important renewable source of pharmaceuticals.     
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APPENDIX 
 
Appendix A. 1H NMR data for I4a (9) (d5-pyridine; 1 mm TXI probe) 
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Appendix B. 1H NMR data for I29 active compounds (11-13) (d4-methanol; 5 mm BBO probe) 
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Appendix C. HSQC NMR data for I29 active compounds (11-13) (d4-methanol; 5 mm BBO 
probe) 
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Appendix D. 1H NMR data for microginin 674 (1) (d6-DMSO; 1 mm TXI probe) 
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Appendix E. TOCSY NMR data for microginin 674 (3) (d6-DMSO; 1 mm TXI probe) 
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Appendix F. HSQC NMR data for microginin 674 (1) d6-DMSO; 1 mm TXI probe) 
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Appendix G. 1H NMR data for microginin 690 (3) (d6-DMSO; 1 mm TXI probe) 
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Appendix H. TOCSY NMR data for microginin 690 (3) (d6-DMSO; 1 mm TXI probe) 
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Appendix I. HSQC NMR data for microginin 690 (3) (d6-DMSO; 1 mm TXI probe) 
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